Participants 15 35 3
children with autism
Participants 322 475 3
children with autism with regard to behavior (aggressiveness, hyperactivity, irritability), social and emotional responsiveness, and communication skills
Participants 477 719 4
We conducted a randomized, double-blind, placebo-controlled trial with 40 consecutive children with autism, whose ages ranged from 2 to 9 years, who were receiving either risperidone or placebo given orally at a dose of 1 mg/day for 6 months.
Participants 922 1043 3
40 children enrolled, 39 completed the trial over a period of 18 months; 19 received risperidone, and 20 received placebo
